Subramanian S - Search Results

1

Subramanian S, Khan F, Hirsch IB. Subramanian S, et al. BMJ. 2024 Jan 26;384:e075681. doi: 10.1136/bmj-2023-075681. BMJ. 2024. PMID: 38278529 Review.

2

Personalized Diabetes Management: Moving from Algorithmic to Individualized Therapy.

Subramanian S, Hirsch IB. Subramanian S, et al. Diabetes Spectr. 2014 May;27(2):87-91. doi: 10.2337/diaspect.27.2.87. Diabetes Spectr. 2014. PMID: 26246764 Free PMC article.

3

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up.

Subramanian S, Hirsch IB. Subramanian S, et al. Endocrinol Metab Clin North Am. 2018 Mar;47(1):65-79. doi: 10.1016/j.ecl.2017.10.012. Epub 2017 Dec 11. Endocrinol Metab Clin North Am. 2018. PMID: 29407057

4

Diabetic Kidney Disease: Is There a Role for Glycemic Variability?

Subramanian S, Hirsch IB. Subramanian S, et al. Curr Diab Rep. 2018 Feb 15;18(3):13. doi: 10.1007/s11892-018-0979-3. Curr Diab Rep. 2018. PMID: 29450720 Review.

5

Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care.

Gigliotti L, Warshaw H, Evert A, Dawkins C, Schwartz J, Susie C, Kushner R, Subramanian S, Handu D, Rozga M. Gigliotti L, et al. Among authors: subramanian s. J Acad Nutr Diet. 2024 Nov 7:S2212-2672(24)00925-0. doi: 10.1016/j.jand.2024.10.023. Online ahead of print. J Acad Nutr Diet. 2024. PMID: 39521378

6

Hypertriglyceridemia secondary to obesity and diabetes.

Subramanian S, Chait A. Subramanian S, et al. Biochim Biophys Acta. 2012 May;1821(5):819-25. doi: 10.1016/j.bbalip.2011.10.003. Epub 2011 Oct 8. Biochim Biophys Acta. 2012. PMID: 22005032 Review.

7

Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects.

Gomes Kjerulf D, Wang S, Omer M, Pathak A, Subramanian S, Han CY, Tang C, den Hartigh LJ, Shao B, Chait A. Gomes Kjerulf D, et al. Among authors: subramanian s. J Diabetes Complications. 2020 Dec;34(12):107693. doi: 10.1016/j.jdiacomp.2020.107693. Epub 2020 Jul 31. J Diabetes Complications. 2020. PMID: 32900591 Free PMC article.

8

Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment.

Wright EE, Subramanian S. Wright EE, et al. Among authors: subramanian s. Diabetes Technol Ther. 2021 Sep;23(S3):S12-S18. doi: 10.1089/dia.2021.0191. Diabetes Technol Ther. 2021. PMID: 34546082 Review.

9

Is Continuous Glucose Monitoring a Tool, an Intervention, or Both?

Wright EE Jr, Subramanian S. Wright EE Jr, et al. Among authors: subramanian s. Diabetes Technol Ther. 2023 Jun;25(S3):S48-S55. doi: 10.1089/dia.2023.0025. Diabetes Technol Ther. 2023. PMID: 37306443

10

Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat.

den Hartigh LJ, Goodspeed L, Wang SA, Kenerson HL, Omer M, O'Brien KD, Ladiges W, Yeung R, Subramanian S. den Hartigh LJ, et al. Among authors: subramanian s. Exp Physiol. 2018 Nov;103(11):1469-1480. doi: 10.1113/EP087207. Epub 2018 Sep 13. Exp Physiol. 2018. PMID: 30117227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,427 results

Search Page

Filters